The End Price Gouging for Medications Act requires the Department of Health and Human Services to set reference prices for prescription drugs.
The End Price Gouging for Medications Act requires the Department of Health and Human Services to establish annual reference prices for each prescription drug. The reference price is determined by the lowest retail list price among reference countries, or by considering therapeutic effect, value, patient access, and research costs if pricing information is unavailable. The reference price applies to federal health programs, including Medicare, Medicaid, and TRICARE. Drug manufacturers must offer drugs at the reference price to all individuals, including those without insurance.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.